MedPath
EMA Product

Exparel liposomal

Product approved by European Medicines Agency (EU)

Basic Information

Exparel liposomal

Regulatory Information

EMEA/H/C/004586

Authorised

November 16, 2020

September 17, 2020

1

November 14, 2022

Company Information

Ireland

Pacira Ireland Limited Unit 13, Dundrum Business Park Classon House Dublin 14 D14 W9Y3

Pacira Ireland Ltd.

Active Substances Detail

Detailed Information

Therapeutic Indication

### Therapeutic indication Exparel liposomal is indicated: - in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. - in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.

Overview Summary

Exparel liposomal is a local anaesthetic that is used to treat pain after certain operations. It can be used in adults and children aged 6 years or older for local pain relief by injecting it around the edges of small to medium-sized surgical wounds. It is also used in adults for regional pain relief by injecting it around the nerves that supply the lower limbs or the shoulder. Exparel liposomal contains the active substance bupivacaine.

© Copyright 2025. All Rights Reserved by MedPath